Therefore, we proposed that the c-Fms-mediated MAPK and PIK3 signaling axis may be the potential mechanism for GCK in the treatment of osteoporosis by interfering with osteoclast differentiation (an overview of the possible molecular mechanism is shown in Figure 10). Here, CSF1R is linked to osteoporosis.